The goal of this program is to improve diagnosis of prostate cancer (PC) using prostate-specific membrane antigen (PSMA)- based imaging, implementation of Radiographic Assessments for Detection of Advanced Recurrence (RADAR) of PC, interpretation of PSMA imaging results, and use of PSMA imaging vs conventional imaging. After hearing and assimilating this program, the clinician will be better able to: 1. Assess the clinical utility of PSMA in the diagnosis and management of prostate cancer. 2. Analyze evidence-based data which support improvement in patient care for prostate cancer through use of PSMA imaging. 3. Outline the recommendations set forth in various RADAR publications. 4. Recognize common pitfalls in the use of PSMA imaging. 5. Appraise the current roles of conventional imaging vs PSMA imaging in prostate cancer.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Urology
- Start Date: 2024-01-02 06:00:00
- End Date: 2024-01-02 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Jointly Provided
- Registration: Open to all